N‐acetyl‐serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF‐κB
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
It is now well established that the formation of free radicals and oxidative stress‐induced neuronal cell death can be involved in various neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. The pineal hormone melatonin has been suggested to be a neuroprotective antioxidant. To better understand the molecular mechanism of this activity, we compared the ability of melatonin and its precursor, N‐acetyl‐serotonin (normelatonin), to protect human neuroblastoma SK‐N‐MC cells and primary cerebellar granular neurons against oxidative stress. We found that normelatonin and melatonin have differential neuroprotective effects depending on the neuronal cell type. Normelatonin was more protective against hydrogen peroxide (H 2 O 2) and glutamate‐induced cell death in SK‐N‐MC cells compared to melatonin which was more effective to protect primary cerebellar granular neurons against the toxicity of H 2 O 2, glutamate and N‐methyl‐D‐aspartate when compared to normelatonin. At the molecular level, we tested the capacity of normelatonin and melatonin to inhibit the oxidative stress‐induced NF‐κB activation in both neuronal systems. Whereas normelatonin was more potent in the suppression of the activation of NF‐κB by H 2 O 2 in SK‐N‐MC cells compared to melatonin, no apparent differences in the extent of suppression could be detected in primary neurons. Normelatonin's and melatonin's neuroprotective activity in SK‐N‐MC neuroblastoma cells may be mediated by the suppression of NF‐κB activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Self-citationMelatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide
Pappolla, M. A., Sos, M., Omar, R. A., Bick, R. J., Hickson-Bick, D. L. M., Reiter, R. J., Efthimiopoulos, S., & Robakis, N. K. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01683.1997 · Cited by 359
Research works printed but not linked: 45
- 10.1073/pnas.90.17.7915 · DOI · Paper page
- 10.1046/j.1471-4159.1997.68052038.x · DOI · Paper page
- 10.1016/S0960-9822(06)00046-7 · DOI · Paper page
- 10.1016/0197-0186(94)00154-M · DOI · Paper page
- 10.1007/s004410050955 · DOI · Paper page
- 10.1016/0006-291X(92)90837-B · DOI · Paper page
- 10.1124/mol.51.4.535 · DOI · Paper page
- 10.1073/pnas.92.16.7297 · DOI · Paper page
- Boussif O., 1996, Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000‐fold, Gene Therapy, 3, 1074
- 10.1016/0896-6273(88)90162-6 · DOI · Paper page
- 10.1006/cbir.1996.0091 · DOI
- 10.1128/MCB.7.2.725 · DOI · Paper page
- 10.1016/0014-4886(95)90005-5 · DOI
- 10.1111/j.1600-079X.1996.tb00263.x · DOI
- 10.1126/science.274.5291.1383 · DOI · Paper page
- 10.1016/0891-5849(89)90057-9 · DOI · Paper page
- 10.1016/0891-5849(89)90057-9 · DOI · Paper page
- Halliwell B., 1989, Free Radicals in Biology and Medicine, 188
- 10.1073/pnas.92.21.9618 · DOI · Paper page
- 10.1038/364535a0 · DOI · Paper page
- Lezoualc'h F., 1997, Activation of the transcription factor NF‐KB as one common molecular signal induced by amyloid β, amylin and hydrogen peroxide, Alzheimer's Res., 3, 43
- Lezoualc'h F., 1997, Transcription factor NF‐KB friend or foe of neurons? Mol, Psychiatry, 3, 15
- 10.1097/00001756-199609020-00003 · DOI
- 10.1038/nm0197-20 · DOI · Paper page
- 10.1046/j.1471-4159.1997.69020581.x · DOI · Paper page
- 10.1046/j.1471-4159.1995.65041740.x · DOI · Paper page
- 10.1016/0024-3205(94)00417-Q · DOI · Paper page
- Meyer M., 1993, H202 and antioxidants have opposite effects on activation of NF‐KB and AP‐I in intact cells: AP‐1 as secondary antioxidant‐responsive factor, EMBO J., 12, 2005, 10.1002/j.1460-2075.1993.tb05850.x · DOI · Paper page
- Mohan N., 1995, The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF‐KB, Biochem. Mol. Biol. Int., 37, 1063
- 10.1016/S0014-5793(97)00961-7 · DOI
- 10.1016/0896-6273(89)90043-3 · DOI · Paper page
- 10.1016/0166-2236(93)90070-3 · DOI · Paper page
- 10.1016/0024-3205(94)00532-X · DOI · Paper page
- 10.1006/frne.1995.1014 · DOI · Paper page
- 10.1111/j.1600-079X.1995.tb00133.x · DOI · Paper page
- 10.1016/1043-2760(95)00192-1 · DOI
- 10.1016/0006-8993(94)91617-9 · DOI
- 10.1073/pnas.87.3.1193 · DOI · Paper page
- Schreck R., 1991, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐KB transcription factor and HIV–1, EMBO J., 10, 2247, 10.1002/j.1460-2075.1991.tb07761.x · DOI · Paper page
- 10.1093/nar/17.15.6419 · DOI · Paper page
- 10.1016/0092-8674(86)90346-6 · DOI · Paper page
- 10.1111/j.1471-4159.1980.tb11222.x · DOI · Paper page
- 10.1002/(SICI)1098-1136(199707)20:3<203::AID-GLIA4>3.0.CO;2-8 · doi:10.1002/(sici)1098-1136(199707)20:3<203::aid-glia4>3.0.co;2-8
- Tan D.X., 1993, Melatonin: A potent, endogenous hydroxyl radical scavenger, Endocrine J., 1, 57
- 10.1016/0891-5849(95)00007-K · DOI
Cited by
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Oxidative damage in the central nervous system: protection by melatonin
Reiter, R. J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00052-5 · Cited by 838
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Advances in the treatment of Parkinson's disease
Singh, N., Pillay, V., & Choonara, Y. E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.009 · Cited by 394
The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer’s disease
Miranda, S., Opazo, C., Larrondo, L. F., Muñoz, F. J., Ruiz, F., Leighton, F., & Inestrosa, N. C. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00015-0 · Cited by 369
Metadata
- Authors
- Lezoualc'h, F., Sparapani, M., & Behl, C.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 1998-04
- Volume
- 24
- Issue
- 3
- Pages
- 168-178
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W2140734226
- Cited by
- 105
- References
- 4
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: N‐acetyl‐serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF‐κB. https://app.cochat.ai/papers/10.1111/j.1600-079x.1998.tb00530.x
- The paper
- Lezoualc'h, F., Sparapani, M., & Behl, C. (1998). N‐acetyl‐serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF‐κB. Journal of Pineal Research. https://doi.org/10.1111/j.1600-079x.1998.tb00530.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.